[vc_row][vc_column width=»1/5″][/vc_column][vc_column width=»4/5″][vc_column_text]

Vaccine Effectiveness Against Long COVID in Children
https://publications.aap.org/pediatrics/article-pdf/doi/10.1542/peds.2023-064446/1592118/peds_2023064446.pdf

COVID-19 Vaccine Effectiveness Among Adolescents
https://publications.aap.org/pediatrics/article-pdf/doi/10.1542/peds.2023-062520/1591286/peds.2023-062520.pdf

Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses
https://www.bmj.com/content/bmj/382/bmj-2022-074325.full.pdf

The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198032/pdf/12941_2023_Article_594.pdf

Memorándum enmienda LT esquema con bivariante en personas con inmunocompromiso
https://bancos.salud.gob.ar/sites/default/files/2023-12/if-2023-143649857-apn-dceims.pdf

Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate
https://www.sciencedirect.com/science/article/pii/S075333222301853X?via%3Dihub

The Proportion of SARS-CoV-2 Infections That Are Asymptomatic
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839426/pdf/aim-olf-M206976.pdf

Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study
https://www.thelancet.com/action/showPdf?pii=S1473-3099%2823%2900374-2

Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study
https://www.thelancet.com/action/showPdf?pii=S2589-5370%2823%2900279-1

Opinions, Attitudes and Factors Related to SARS-CoV-2 Vaccine Uptake in Eight South American Countries
https://www.mdpi.com/2076-393X/11/11/1660

Effectiveness of BNT162b2 vaccine against symptomatic SARS-CoV-2 infection in children aged 5−11 years in Japan during Omicron variant predominate periods
https://www.jstage.jst.go.jp/article/jea/advpub/0/advpub_JE20230093/_article

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

https://www.thelancet.com/action/showPdf?pii=S1473-3099%2823%2900299-2

Tratamiento corticoide y variantes SARS-CoV-2: dos factores independientes de mortalidad por COVID-19 en un hospital comarcal
https://recyt.fecyt.es/index.php/ASSN/article/view/95536/72567

Higiene con clorhexidina en unidades de cuidados intensivos para prevenir infecciones nosocomiales. Revisión sistemática
https://recyt.fecyt.es/index.php/ASSN/article/view/94805/70984

Diferencias y similitudes entre la cefalea relacionada con la COVID-19 y la cefalea relacionada con la vacuna de la COVID-19. Un estudio de casos y controles
https://neurologia.com/noticia/9392/diferencias-y-similitudes-entre-la-cefalea-relacionada-con-la-covid-19-y-la-cefalea-relacionada-con-la-vacuna-de-la-covid-19-un-estudio-de-casos-y-controles

Plant virus-derived nanoparticles decorated with genetically encoded SARS-CoV-2 nanobodies display enhanced neutralizing activity
https://onlinelibrary.wiley.com/doi/epdf/10.1111/pbi.14230

Neuropathic symptoms with SARS-CoV-2 vaccination
https://pubmed.ncbi.nlm.nih.gov/35611338/

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial
https://www.thelancet.com/action/showPdf?pii=S1473-3099%2823%2900299-2

Comparison of SARS-CoV-2 viral load in asymptomatic and symptomatic children attended in a referral public pediatric hospital in Argentina
https://panel.aam.org.ar/img_up/07072023.5.pdf

Effect of covid-19 vaccination on long covid: systematic review
https://bmjmedicine.bmj.com/content/bmjmed/2/1/e000385.full.pdf

Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program
https://www.nature.com/articles/s41467-023-38388-7.pdf

Risk factors associated with post-COVID-19 condition: A systematic review and meta-analysis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037203/

A prospective cohort study of preconception COVID-19 vaccination and miscarriage
https://academic.oup.com/humrep/advance-article-abstract/doi/10.1093/humrep/dead211/7326030?redirectedFrom=fulltext&login=false

Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men
https://www.nature.com/articles/s41467-023-39766-x.pdf

Heart Rate Variability in Normotensive and Hypertensive Adults After a Year of Receiving Oxford/AstraZeneca COVID-19 Vaccine: A Cross-Sectional Observational Study
https://assets.cureus.com/uploads/original_article/pdf/161895/20230707-25326-1srjzgp.pdf

Melatonin, vitamins and minerals supplements for the treatment of Covid-19 and Covid-like illness: A prospective, randomized, double-blind multicenter study
https://www.sciencedirect.com/science/article/pii/S1550830723001295?via%3Dihub#abs0001

Efficacy and safety of convalescent plasma administration in patients with COVID-19
https://www.sciencedirect.com/science/article/pii/S0025775323003111?via%3Dihub

COVID-19 vaccination effectiveness and safety in vulnerable populations: a meta-analysis of 33 observational studies
https://www.frontiersin.org/articles/10.3389/fphar.2023.1144824/full

Determining the Time of Booster Dose Based on the Half-Life and Neutralization Titers against SARS-CoV-2 Variants of Concern in Fully Vaccinated Individuals
https://journals.asm.org/doi/epdf/10.1128/spectrum.04081-22

Comparison of antibody persistency through one year between one-dose and two-dose regimens of Ad5-nCoV vaccine for COVID-19
https://www.tandfonline.com/doi/epdf/10.1080/21645515.2023.2230760?needAccess=true&role=button

Simvastatin in Critically Ill Patients with Covid-19
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2309995?articleTools=true

Intravenous Vitamin C for Patients Hospitalized With COVID-19. Two Harmonized Randomized Clinical Trials
https://jamanetwork.com/journals/jama/articlepdf/2811212/jama_adhikari_2023_oi_230127_1698082231.25895.pdf

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes
https://www.nature.com/articles/s41586-023-06649-6.epdf

Impact of Inhaled Epoprostenol in Patients on COVID-19 Acute Respiratory Distress Syndrome (ARDS)
https://scholarlycommons.hcahealthcare.com/cgi/viewcontent.cgi?article=1563&context=hcahealthcarejournal

COVID-19 Update: New Pfizer and Moderna Vaccine Formulations for 2023-2024
https://secure.medicalletter.org/TML-article-1687c

Highlights from the Meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization 25-29 September 2023
https://cdn.who.int/media/docs/default-source/immunization/sage/2023/september/sage_sept2023_meeting_highlights.pdf?sfvrsn=5ac08c01_4&download=true

Multivalent vaccines against new SARS-CoV-2 hybrid variants
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212962/pdf/main.pdf

Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months
https://elifesciences.org/articles/85009v1

Avance de la investigación sobre la ivermectina en el tratamiento de la COVID-19
https://revfarmacia.sld.cu/index.php/far/article/view/905/540

Plantas medicinales contra la COVID-19: ¿una alternativa en la prevención?
https://www.sciencedirect.com/science/article/pii/S0212656723001427/pdfft?md5=703a14641f727a93aeb8a2ce5298c57b&pid=1-s2.0-S0212656723001427-main.pdf

Optic neuritis associated with COVID-19-related vaccines
https://www.sciencedirect.com/science/article/pii/S1576988722001960/pdfft?md5=9a73d4acac7651bcbc9f04254912b094&pid=1-s2.0-S1576988722001960-main.pdf

Corticosteroid-Associated Avascular Necrosis of the Femoral Head in Patients with Severe COVID-19: A Single-Center Study
https://medscimonit.com/abstract/index/idArt/940965

Efficacy and Safety of Molnupiravir Treatment for COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214763/pdf/main.pdf

Real-world effectiveness and factors associated with increased mortality in non-critically ill patients with COVID-19 pneumonia receiving remdesivir
https://ejhp.bmj.com/content/ejhpharm/early/2023/06/19/ejhpharm-2023-003729.full.pdf

Vacunación frente a la COVID-19 a partir de los 6 meses de edad. Completando el círculo de la prevención en Pediatría
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790871/pdf/main.pdf

Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531663/pdf/main.pdf

Blood Group A Enhances SARS-CoV-2 Infection
https://ashpublications.org/blood/article-pdf/doi/10.1182/blood.2022018903/2059681/blood.2022018903.pdf

The role of high cholesterol in SARS-CoV-2 infectivity
https://www.jbc.org/action/showPdf?pii=S0021-9258%2823%2901791-X

Major update: Masks for prevention of SARS-CoV-2 in health care and community settings – Final update of a living, rapid review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234287/pdf/aim-olf-M230570.pdf

Vacunación contra el SARS-CoV-2 en pacientes pediátricos con epilepsia: experiencia de un centro terciario en Colombia
https://neurologia.com/articulo/2023127

COVID-19 Update: New Pfizer and Moderna Vaccine Formulations for 2023-2024
https://secure.medicalletter.org/TML-article-5067a

Effects of the COVID-19 booster vaccine on glycemia and insulin resistance in people with type 1 diabetes: A prospective pilot study
https://pubmed.ncbi.nlm.nih.gov/37678726/

Increased vaccine sensitivity of an emerging SARS-CoV-2 variant
https://www.nature.com/articles/s41467-023-39567-2.pdf

The Efficacy of Long-Term Hydroxychloroquine Use in the Prevention of COVID-19: A Retrospective Cohort Study
https://ebooks.iospress.nl/doi/10.3233/SHTI230489

Actualización sobre eficacia y seguridad de molnupiravir en pacientes con COVID-19 con alto riesgo de desarrollo de enfermedad grave
https://www.boletinfarmacologia.hc.edu.uy/images/stories/boletin/boletn_molnupiravir_covid-19_actualizacin_23_1_1.pdf

¿Cuál es la eficacia y seguridad de nirmatrelvir/ritonavir en la COVID-19 con alto riesgo de desarrollo de enfermedad grave?
https://www.boletinfarmacologia.hc.edu.uy/images/stories/boletin/boletn_paxlovid_1.pdf

Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases – an ACCESS cohort study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678835/pdf/main.pdf

Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
https://www.thelancet.com/action/showPdf?pii=S0140-6736%2822%2902465-5

The effectiveness of coronavirus disease 2019 (COVID-19) vaccine in the prevention of post–COVID-19 conditions: A systematic literature review and meta-analysis https://www.cambridge.org/core/services/aop-cambridge-core/content/view/0AD0EDEC8C9CC9DF455752E32D73147B/S2732494X22003369a.pdf/the-effectiveness-of-coronavirus-disease-2019-covid-19-vaccine-in-the-prevention-of-postcovid-19-conditions-a-systematic-literature-review-and-meta-analysis.pdf

Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial. https://jamanetwork.com/journals/jama/fullarticle/2801827

Impact of COVID-19 Pandemic in Antibiotic Consumption in Navarre (Spain): An Interrupted Time Series Analysis.
https://www.mdpi.com/2079-6382/12/2/318

Long-term effectiveness of COVID-19 vaccines against infections, hospitalizations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022
https://www.thelancet.com/action/showPdf?pii=S2213-2600%2823%2900015-2

Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study
https://www.cmaj.ca/content/cmaj/194/45/E1529.full.pdf

The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681154/pdf/fphar-13-1011522.pdf

Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
https://www.thelancet.com/pdfs/journals/lanres/PIIS2213-2600(22)00299-5.pdf

Systemic corticosteroids for the treatment of COVID‐19: Equity‐related analyses and update on evidence
https://www.cochranelibrary.com/es/cdsr/doi/10.1002/14651858.CD014963.pub2/epdf/full

Evaluación de la performance de 4 kits comerciales de testeo rápido antigénico de SARS COV-2 en el diagnóstico de COVID-19
https://www.revistabypc.org.ar/index.php/bypc/article/view/215/520

Vigilancia sanitaria de COVID-19 en animales y medio ambiente
https://www.newmedicaleconomics.es/wp-content/uploads/2023/07/7.pdf

Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2798504/akpandak_2022_oi_221191_1667839528.24171.pdf

Saliva-based methods for SARS-CoV-2 testing in low- and middle-income countries
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706358/pdf/BLT.22.288526.pdf

Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis
https://www.jacc.org/doi/10.1016/j.jacc.2022.09.049

Associations between indoor relative humidity and global COVID-19 outcomes
https://royalsocietypublishing.org/doi/epdf/10.1098/rsif.2021.0865

Guía práctica de las nuevas alternativas terapéuticas frente a SARS-CoV-2 en pacientes con inmunomoduladores de uso frecuente en dermatología
https://www.actasdermo.org/es-pdf-S0001731022006871

Functional neurological disorders after COVID-19 vaccination: Case series and literature review
https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcn.13453

Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy
https://www.medrxiv.org/content/10.1101/2022.04.20.22274090v1

Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study
https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-022-07696-6.pdf

Comparative Effectiveness of Mask Type in Preventing SARS-CoV-2 in Health Care Workers: Uncertainty Persists
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707439/pdf/aim-olf-M223219.pdf

Associations between indoor relative humidity and global COVID-19 outcomes
https://royalsocietypublishing.org/doi/epdf/10.1098/rsif.2021.0865

Guía práctica de las nuevas alternativas terapéuticas frente a SARS-CoV-2 en pacientes con inmunomoduladores de uso frecuente en dermatología
https://www.actasdermo.org/es-pdf-S0001731022006871

Functional neurological disorders after COVID-19 vaccination: Case series and literature review
https://onlinelibrary.wiley.com/doi/pdf/10.1111/pcn.13453

Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy
https://www.medrxiv.org/content/10.1101/2022.04.20.22274090v1

Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study
https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-022-07696-6.pdf

Vacunación contra el SARS-CoV-2 en pacientes pediátricos con epilepsia: experiencia de un centro terciario en Colombia
https://neurologia.com/articulo/2023127/esp

Neutralization of Omicron Subvariant BA.2.75 after Bivalent Vaccination
https://www.nejm.org/doi/pdf/10.1056/NEJMc2212772?articleTools=true

HIV, HSV, SARS-CoV-2 and Ebola Share Long-Term Neuropsychiatric Sequelae
https://www.dovepress.com/getfile.php?fileID=84456

Current Treatments for COVID-19: Application of Supercritical Fluids in the Manufacturing of Oral and Pulmonary Formulations

https://www.mdpi.com/1999-4923/14/11/2380/pdf?version=1668394133

Reactivación del virus varicela zóster tras la vacunación contra la COVID-19
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108032/pdf/main.pdf

Caracterización de las manifestaciones cutáneas por infección de SARS-COV-2 en pacientes de América Latina
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995250/pdf/main.pdf

Exacerbación de psoriasis secundaria a infección por SARS-CoV-2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141715/pdf/main.pdf

Urticaria 12 Days After COVID-19 mRNA Booster Vaccination
https://jamanetwork.com/journals/jama/articlepdf/2791317/jama_wolfson_2022_cg_220004_1650666732.19995.pdf

Spikevax booster and delayed urticaria: a Swiss signal with diagnostic uncertainties due to a high proportion of direct patient reports
https://link.springer.com/content/pdf/10.1007/s00228-022-03404-0.pdf

Cutaneous reactions following booster dose administration of COVID-19 mRNA vaccine: A first look from the American Academy of Dermatology/International League of Dermatologic Societies registry
https://www.jaadinternational.org/article/S2666-3287(22)00050-5/pdf

Chronic spontaneous urticaria after COVID-19 primary vaccine series and boosters
https://www.jaadcasereports.org/article/S2352-5126(22)00224-7/pdf

Shoulder injury related to vaccine administration (SIRVA): What do we know about its incidence and impact?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576975/pdf/main.pdf

Hypertension and Excess Risk for Severe COVID-19 Illness Despite Booster Vaccination
https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.122.19694

Mechanisms of COVID-19 pathogenesis in diabetes
https://journals.physiology.org/doi/epdf/10.1152/ajpheart.00204.2022

Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425709/pdf/aim-olf-M220988.pdf

Acute Arterial Ischemic Stroke Following COVID-19 Vaccination. A Systematic Review and Meta-analysis
https://n.neurology.org/content/99/14/e1465

Múltiples reacciones adversas graves a fármacos en un paciente luego de la infección por COVID-19. Informe de un caso
https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/260/134

Allergists and COVID-vaccine: which is the actual risk of reactions in allergic patients?
https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/13006/11057

Association of Symptoms After COVID-19 Vaccination With Anti–SARS-CoV-2 Antibody Response in the Framingham Heart Study
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2797552

Duration of immunity following full vaccination against SARS-CoV-2: a systematic review
https://archpublichealth.biomedcentral.com/counter/pdf/10.1186/s13690-022-00935-x.pdf

Comparative effectiveness of N95, surgical or medical, and non-medical facemasks in protection against respiratory virus infection: A systematic review and network meta-analysis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111143/pdf/RMV-32-0.pdf

Antiviral Activity of Echinacea Extract Appears to Include SARS-CoV-2
https://www.herbalgram.org/media/17794/032223.pdf

SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants
https://www.frontiersin.org/articles/10.3389/fimmu.2022.909995/pdf

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age
https://www.nejm.org/doi/pdf/10.1056/NEJMoa2209367?articleTools=true

Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England
https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797625/strasser_2022_oi_221086_1666016864.51241.pdf

Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
https://www.science.org/doi/epdf/10.1126/science.abo2523

A multinational Delphi consensus to end the COVID-19 public health threat
https://www.nature.com/articles/s41586-022-05398-2.pdf

Gout and Excess Risk of Severe SARS-CoV-2 Infection Among Vaccinated Individuals: A General Population Study
https://onlinelibrary.wiley.com/doi/10.1002/art.42339

Síndrome de Gianotti-Crosti de localización atípica en un adulto después de la vacunación contra el SARS-CoV-2
https://www.actasdermo.org/es-pdf-S0001731023000443

Shoulder injury related to vaccine administration (SIRVA): What do we know about its incidence and impact?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576975/pdf/main.pdf

[vc_row][vc_column][vc_column_text]

La Biblioteca le brinda un dossier informativo actualizado sobre Coronavirus (COVID-19)

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column width=»1/5″][/vc_column][vc_column width=»1/5″][vc_btn title=»Artículos científicos» style=»custom» custom_background=»#13a800″ custom_text=»#ffffff» shape=»square» align=»center» button_block=»true» link=»url:https%3A%2F%2Fwww.colfarma.info%2Fcolfarma%2Farticulos-cientificos%2F»][/vc_column][vc_column width=»1/5″][vc_btn title=»Sociedades científicas: Recursos» style=»custom» custom_background=»#a81e1e» custom_text=»#ffffff» shape=»square» align=»center» button_block=»true» link=»url:https%3A%2F%2Fwww.colfarma.info%2Fcolfarma%2Fsociedades-cientificas-recursos%2F»][/vc_column][vc_column width=»1/5″][vc_btn title=»Organización Panamericana de la Salud (OPS) – Argentina / CDC» style=»custom» custom_background=»#014daf» custom_text=»#ffffff» shape=»square» align=»center» button_block=»true» link=»url:https%3A%2F%2Fwww.colfarma.info%2Fcolfarma%2Forganizacion-panamericana-de-la-salud-ops-argentina-cdc%2F»][/vc_column][vc_column width=»1/5″][/vc_column][/vc_row]